Language: BG BG
← Back to results
Recruiting NCT07351916

Remission in Adults With Mild-to-moderate Asthma in Thailand

Conditions: Asthma Mild-to-moderate Asthma Asthma Control Level

Sponsor: Thammasat University

trial.available_in: БГ
Overview
The goal of this observational study is to determine the prevalence of remission among adults with mild-to-moderate asthma, as well as the factors associated with remission in Thailand. The main question the study aims to answer is: What is the prevalence of remission among adults with severe asthma in Thailand? Participants will complete a questionnaire on asthma symptoms and undergo pulmonary function testing and a blood test once.
Description
This study is a cross-sectional study. Thai patients aged 18 years or older with mild-to-moderate asthma are included in the study. Participants will complete two questionnaires about asthma control: the Global Initiative for Asthma (GINA) and the Asthma Control Test (ACT), and will perform spirometry, a fractional exhaled nitric oxide (FeNO) test, and blood eosinophil counts (BEC). GINA and ACT are questionnaires used to assess the level of asthma control.
Who can participate
Inclusion Criteria: * mild-to-moderate asthma * age 18 years or older Exclusion Criteria: * inability to perform spirometry or fractional exhaled nitric oxide (FeNO) test
Interventions
Global Initiative for Asthma (GINA) and Asthma Control Test (ACT) questionnaires
OTHER
Spirometry
OTHER
Fractional exhaled nitric oxide (FeNO) test
OTHER
Blood eosinophil count (BEC)
OTHER
Locations 2
Thailand (2)
Narongkorn Saiphoklang
Pathum Thani , Changwat Pathum Thani
Narongkorn Saiphoklang, MD
Faculty of Medicine, Thammasat University
Pathum Thani
Narongkorn Saiphoklang, MD
Technical details
Status
Recruiting
Study type
OBSERVATIONAL
Sex
Male and female
Minimum age
18 Years
Healthy volunteers
No
Start date
01.02.2026
Completion date
31.12.2026
Registry ID
NCT07351916
Source
clinicaltrials.gov
trial.inquiry_btn

Information is automatically extracted from ClinicalTrials.gov. Consult your doctor before taking action.